Loading...
Please wait, while we are loading the content...
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan.
| Content Provider | Europe PMC |
|---|---|
| Author | Kashiwagi, Atsunori Shoji, Shingo Kosakai, Yoshinori Koga, Tadashi Asakawa, Keiko Rokuda, Mitsuhiro |
| Page Count | 416 |
| ISSN | 20401116 |
| Journal | Journal of Diabetes Investigation |
| Volume Number | 14 |
| PubMed Central reference number | PMC9951561 |
| Issue Number | 3 |
| PubMed reference number | 36515129 |
| e-ISSN | 20401124 |
| DOI | 10.1111/jdi.13952 |
| Language | English |
| Publisher | John Wiley and Sons Inc. |
| Publisher Date | 2022-12-14 |
| Publisher Place | Hoboken |
| Access Restriction | Open |
| Rights License | This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. © 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. |
| Subject Keyword | Cardiometabolic risk factors Diabetes mellitus type 2 Sodium–glucose cotransporter 2 inhibitors |
| Content Type | Text |
| Resource Type | Article |
| Subject | Endocrinology, Diabetes and Metabolism Internal Medicine |